A case report on efficacy of Abound™ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer

BACKGROUND: Panitumumab is a full human epidermal growth factor receptor (EGFR) monoclonal antibody, an agent for metastatic colorectal cancer therapy. One of the most general adverse events of anti-EGFR monoclonal antibody therapy is skin disorder. At the present time, although prophylaxis of skin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Matsuhashi, Nobuhisa, Takahashi, Takao, Nonaka, Kenichi, Ichikawa, Kengo, Yawata, Kazunori, Tanahashi, Toshiyuki, Imai, Hisashi, Sasaki, Yoshiyuki, Tanaka, Yoshihiro, Okumura, Naoki, Yamaguchi, Kazuya, Osada, Shinji, Yoshida, Kazuhiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922949/
https://ncbi.nlm.nih.gov/pubmed/24517087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-12-35
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados